Inhibition of virus induced Aggravation of childhood asthma by Salmeterol/Fluticasone Propionate Combination(SFC)

JRCT ID: jRCTs031180304

Registered date:15/03/2019

Basic Information

• Recruitment status: Recruiting
• Health condition(s) or Problem(s) studied: Asthma
• Date of first enrollment: 28/10/2016
• Target sample size: 36
• Study type: Interventional
• Intervention(s): Divide into Fluticasone control group and SFC control group

Outcome(s)

• Primary Outcome: In patients with a common cold, asthma control was significantly more effective for those treated with SFC compared to treatment with Fluticasone

Secondary Outcome

In 12th week SFC group will show higher Best ACT P score and QOL score than fluticasone group.
SFC group will less frequently to use b stimulator and less frequently to visit ER department.

Key inclusion & exclusion criteria

• Age minimum: >= 6month old
• Age maximum: <= 2age old
• Gender: Both

Include criteria

Physician diagnosed asthma(
More than 3 wheeze episode)
More than 2 asthma attacks for 8 weeks
LTRA is taken for more than 1month as a controller

Exclude criteria

SFC or Fluticasone is used as a controller
Patients has respiratory diseases except asthma

Related Information

• Primary Sponsor: Yoshihara Shigemi
• Secondary ID(s): UMIN 000023224